GPX4 and hepatocellular carcinoma: More importantly, the reason why miR-23a-3p makes HCC cells sorafenib resistant is that it down-regulates ACSL4 expression, increases GPX4 expression, reduces Fe2+ and lipid ROS content, and puts cells in a high antioxidant state.